Fluorine in PDB 8uv2: Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
Enzymatic activity of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
All present enzymatic activity of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer):
3.6.4.6;
Fluorine Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
12;
Binding sites:
The binding sites of Fluorine atom in the Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
(pdb code 8uv2). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 12 binding sites of Fluorine where determined in the
Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer), PDB code: 8uv2:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Fluorine binding site 1 out
of 12 in 8uv2
Go back to
Fluorine Binding Sites List in 8uv2
Fluorine binding site 1 out
of 12 in the Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F903
b:35.6
occ:1.00
|
F17
|
A:XKM903
|
0.0
|
35.6
|
1.0
|
C16
|
A:XKM903
|
1.3
|
31.6
|
1.0
|
C18
|
A:XKM903
|
2.2
|
22.6
|
1.0
|
C15
|
A:XKM903
|
2.3
|
32.0
|
1.0
|
C14
|
A:XKM903
|
2.8
|
20.9
|
1.0
|
CD1
|
A:LEU504
|
3.0
|
28.3
|
1.0
|
O
|
A:PRO500
|
3.1
|
21.2
|
1.0
|
CB
|
A:PRO500
|
3.3
|
26.8
|
1.0
|
CB
|
A:PHE503
|
3.3
|
20.2
|
1.0
|
CA
|
A:PRO500
|
3.4
|
21.7
|
1.0
|
C19
|
A:XKM903
|
3.4
|
27.6
|
1.0
|
C41
|
A:XKM903
|
3.5
|
34.9
|
1.0
|
C
|
A:PRO500
|
3.7
|
21.3
|
1.0
|
C13
|
A:XKM903
|
3.7
|
22.4
|
1.0
|
C40
|
A:XKM903
|
4.0
|
29.2
|
1.0
|
N
|
A:LEU504
|
4.1
|
29.5
|
1.0
|
C
|
A:PHE503
|
4.2
|
26.0
|
1.0
|
CA
|
A:PHE503
|
4.2
|
16.4
|
1.0
|
CG
|
A:PHE503
|
4.3
|
22.8
|
1.0
|
O20
|
A:XKM903
|
4.4
|
36.1
|
1.0
|
CG
|
A:LEU504
|
4.5
|
30.4
|
1.0
|
O
|
A:PRO496
|
4.6
|
36.4
|
1.0
|
F42
|
A:XKM903
|
4.7
|
35.6
|
1.0
|
N
|
A:PHE503
|
4.7
|
19.4
|
1.0
|
CG
|
A:PRO500
|
4.7
|
31.1
|
1.0
|
O
|
A:PHE503
|
4.7
|
32.3
|
1.0
|
N
|
A:PRO500
|
4.8
|
18.4
|
1.0
|
CB
|
A:LEU504
|
4.8
|
29.4
|
1.0
|
CA
|
A:LEU504
|
4.9
|
30.4
|
1.0
|
CD1
|
A:PHE503
|
4.9
|
26.8
|
1.0
|
C12
|
A:XKM903
|
5.0
|
28.4
|
1.0
|
N
|
A:ASP501
|
5.0
|
23.5
|
1.0
|
|
Fluorine binding site 2 out
of 12 in 8uv2
Go back to
Fluorine Binding Sites List in 8uv2
Fluorine binding site 2 out
of 12 in the Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F903
b:35.6
occ:1.00
|
F42
|
A:XKM903
|
0.0
|
35.6
|
1.0
|
C41
|
A:XKM903
|
1.3
|
34.9
|
1.0
|
C40
|
A:XKM903
|
2.3
|
29.2
|
1.0
|
C15
|
A:XKM903
|
2.4
|
32.0
|
1.0
|
C14
|
A:XKM903
|
2.9
|
20.9
|
1.0
|
CD
|
A:PRO510
|
3.4
|
23.9
|
1.0
|
C16
|
A:XKM903
|
3.5
|
31.6
|
1.0
|
C19
|
A:XKM903
|
3.5
|
27.6
|
1.0
|
C13
|
A:XKM903
|
3.7
|
22.4
|
1.0
|
NZ
|
A:LYS615
|
3.8
|
20.3
|
1.0
|
CG
|
A:PRO510
|
3.9
|
15.8
|
1.0
|
C18
|
A:XKM903
|
4.0
|
22.6
|
1.0
|
CE
|
A:LYS615
|
4.0
|
23.1
|
1.0
|
CD
|
A:LYS615
|
4.1
|
30.8
|
1.0
|
CA
|
A:THR509
|
4.1
|
28.1
|
1.0
|
N
|
A:PRO510
|
4.2
|
15.9
|
1.0
|
C
|
A:THR509
|
4.5
|
21.0
|
1.0
|
N36
|
A:XKM903
|
4.5
|
28.0
|
1.0
|
F17
|
A:XKM903
|
4.7
|
35.6
|
1.0
|
O20
|
A:XKM903
|
4.7
|
36.1
|
1.0
|
C35
|
A:XKM903
|
4.8
|
32.0
|
1.0
|
N
|
A:THR509
|
4.9
|
27.8
|
1.0
|
CB
|
A:THR509
|
5.0
|
30.9
|
1.0
|
|
Fluorine binding site 3 out
of 12 in 8uv2
Go back to
Fluorine Binding Sites List in 8uv2
Fluorine binding site 3 out
of 12 in the Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F903
b:64.1
occ:1.00
|
F17
|
B:XKM903
|
0.0
|
64.1
|
1.0
|
C16
|
B:XKM903
|
1.3
|
67.9
|
1.0
|
C18
|
B:XKM903
|
2.2
|
63.3
|
1.0
|
C15
|
B:XKM903
|
2.3
|
68.9
|
1.0
|
C14
|
B:XKM903
|
2.9
|
61.9
|
1.0
|
CD1
|
B:LEU504
|
3.0
|
31.8
|
1.0
|
O
|
B:PRO500
|
3.1
|
28.3
|
1.0
|
CB
|
B:PRO500
|
3.2
|
28.8
|
1.0
|
CB
|
B:PHE503
|
3.3
|
19.9
|
1.0
|
CA
|
B:PRO500
|
3.3
|
23.0
|
1.0
|
C19
|
B:XKM903
|
3.4
|
65.3
|
1.0
|
C41
|
B:XKM903
|
3.5
|
68.3
|
1.0
|
C
|
B:PRO500
|
3.6
|
27.1
|
1.0
|
C13
|
B:XKM903
|
3.7
|
59.5
|
1.0
|
N
|
B:LEU504
|
4.0
|
35.0
|
1.0
|
C40
|
B:XKM903
|
4.0
|
66.8
|
1.0
|
C
|
B:PHE503
|
4.2
|
34.4
|
1.0
|
CA
|
B:PHE503
|
4.3
|
25.9
|
1.0
|
CG
|
B:PHE503
|
4.3
|
22.7
|
1.0
|
O20
|
B:XKM903
|
4.4
|
67.0
|
1.0
|
CG
|
B:LEU504
|
4.5
|
40.5
|
1.0
|
O
|
B:PRO496
|
4.6
|
39.8
|
1.0
|
F42
|
B:XKM903
|
4.7
|
64.7
|
1.0
|
N
|
B:PHE503
|
4.7
|
26.2
|
1.0
|
CG
|
B:PRO500
|
4.7
|
32.8
|
1.0
|
N
|
B:PRO500
|
4.7
|
17.9
|
1.0
|
CB
|
B:LEU504
|
4.8
|
37.5
|
1.0
|
CA
|
B:LEU504
|
4.8
|
35.3
|
1.0
|
CD1
|
B:PHE503
|
4.8
|
31.4
|
1.0
|
O
|
B:PHE503
|
4.9
|
36.6
|
1.0
|
N
|
B:ASP501
|
4.9
|
30.1
|
1.0
|
C12
|
B:XKM903
|
5.0
|
62.3
|
1.0
|
|
Fluorine binding site 4 out
of 12 in 8uv2
Go back to
Fluorine Binding Sites List in 8uv2
Fluorine binding site 4 out
of 12 in the Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F903
b:64.7
occ:1.00
|
F42
|
B:XKM903
|
0.0
|
64.7
|
1.0
|
C41
|
B:XKM903
|
1.3
|
68.3
|
1.0
|
C40
|
B:XKM903
|
2.3
|
66.8
|
1.0
|
C15
|
B:XKM903
|
2.4
|
68.9
|
1.0
|
C14
|
B:XKM903
|
2.9
|
61.9
|
1.0
|
CD
|
B:PRO510
|
3.4
|
33.0
|
1.0
|
C16
|
B:XKM903
|
3.5
|
67.9
|
1.0
|
C19
|
B:XKM903
|
3.5
|
65.3
|
1.0
|
C13
|
B:XKM903
|
3.7
|
59.5
|
1.0
|
NZ
|
B:LYS615
|
3.9
|
28.2
|
1.0
|
CG
|
B:PRO510
|
3.9
|
20.4
|
1.0
|
C18
|
B:XKM903
|
4.0
|
63.3
|
1.0
|
CE
|
B:LYS615
|
4.0
|
27.8
|
1.0
|
CD
|
B:LYS615
|
4.1
|
30.6
|
1.0
|
CA
|
B:THR509
|
4.1
|
35.4
|
1.0
|
N
|
B:PRO510
|
4.2
|
25.7
|
1.0
|
N36
|
B:XKM903
|
4.5
|
64.6
|
1.0
|
C
|
B:THR509
|
4.5
|
29.2
|
1.0
|
F17
|
B:XKM903
|
4.7
|
64.1
|
1.0
|
C35
|
B:XKM903
|
4.7
|
63.5
|
1.0
|
O20
|
B:XKM903
|
4.7
|
67.0
|
1.0
|
N
|
B:THR509
|
4.9
|
35.8
|
1.0
|
|
Fluorine binding site 5 out
of 12 in 8uv2
Go back to
Fluorine Binding Sites List in 8uv2
Fluorine binding site 5 out
of 12 in the Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F903
b:64.0
occ:1.00
|
F17
|
C:XKM903
|
0.0
|
64.0
|
1.0
|
C16
|
C:XKM903
|
1.3
|
68.5
|
1.0
|
C18
|
C:XKM903
|
2.2
|
65.9
|
1.0
|
C15
|
C:XKM903
|
2.3
|
69.6
|
1.0
|
C14
|
C:XKM903
|
2.9
|
61.3
|
1.0
|
O
|
C:PRO500
|
3.0
|
27.2
|
1.0
|
CD1
|
C:LEU504
|
3.0
|
30.0
|
1.0
|
CB
|
C:PRO500
|
3.3
|
23.2
|
1.0
|
CB
|
C:PHE503
|
3.3
|
17.6
|
1.0
|
CA
|
C:PRO500
|
3.4
|
19.5
|
1.0
|
C19
|
C:XKM903
|
3.4
|
68.0
|
1.0
|
C41
|
C:XKM903
|
3.5
|
69.1
|
1.0
|
C
|
C:PRO500
|
3.6
|
23.9
|
1.0
|
C13
|
C:XKM903
|
3.7
|
58.6
|
1.0
|
N
|
C:LEU504
|
4.0
|
31.1
|
1.0
|
C40
|
C:XKM903
|
4.0
|
67.6
|
1.0
|
C
|
C:PHE503
|
4.2
|
31.4
|
1.0
|
CA
|
C:PHE503
|
4.3
|
23.8
|
1.0
|
CG
|
C:PHE503
|
4.3
|
22.8
|
1.0
|
O20
|
C:XKM903
|
4.4
|
68.8
|
1.0
|
CG
|
C:LEU504
|
4.5
|
36.7
|
1.0
|
O
|
C:PRO496
|
4.6
|
33.5
|
1.0
|
F42
|
C:XKM903
|
4.7
|
64.8
|
1.0
|
N
|
C:PHE503
|
4.7
|
25.4
|
1.0
|
CG
|
C:PRO500
|
4.7
|
30.5
|
1.0
|
N
|
C:PRO500
|
4.8
|
17.0
|
1.0
|
CB
|
C:LEU504
|
4.8
|
35.2
|
1.0
|
CA
|
C:LEU504
|
4.8
|
33.7
|
1.0
|
CD1
|
C:PHE503
|
4.9
|
29.4
|
1.0
|
O
|
C:PHE503
|
4.9
|
35.0
|
1.0
|
N
|
C:ASP501
|
4.9
|
22.8
|
1.0
|
C12
|
C:XKM903
|
5.0
|
63.2
|
1.0
|
|
Fluorine binding site 6 out
of 12 in 8uv2
Go back to
Fluorine Binding Sites List in 8uv2
Fluorine binding site 6 out
of 12 in the Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F903
b:64.8
occ:1.00
|
F42
|
C:XKM903
|
0.0
|
64.8
|
1.0
|
C41
|
C:XKM903
|
1.3
|
69.1
|
1.0
|
C40
|
C:XKM903
|
2.3
|
67.6
|
1.0
|
C15
|
C:XKM903
|
2.4
|
69.6
|
1.0
|
C14
|
C:XKM903
|
2.9
|
61.3
|
1.0
|
CD
|
C:PRO510
|
3.4
|
27.1
|
1.0
|
C16
|
C:XKM903
|
3.5
|
68.5
|
1.0
|
C19
|
C:XKM903
|
3.5
|
68.0
|
1.0
|
C13
|
C:XKM903
|
3.7
|
58.6
|
1.0
|
NZ
|
C:LYS615
|
3.8
|
22.8
|
1.0
|
CG
|
C:PRO510
|
3.9
|
17.0
|
1.0
|
C18
|
C:XKM903
|
4.0
|
65.9
|
1.0
|
CE
|
C:LYS615
|
4.0
|
22.6
|
1.0
|
CD
|
C:LYS615
|
4.1
|
27.4
|
1.0
|
CA
|
C:THR509
|
4.1
|
29.5
|
1.0
|
N
|
C:PRO510
|
4.2
|
20.9
|
1.0
|
N36
|
C:XKM903
|
4.5
|
64.6
|
1.0
|
C
|
C:THR509
|
4.5
|
23.9
|
1.0
|
F17
|
C:XKM903
|
4.7
|
64.0
|
1.0
|
O20
|
C:XKM903
|
4.7
|
68.8
|
1.0
|
C35
|
C:XKM903
|
4.7
|
65.3
|
1.0
|
N
|
C:THR509
|
4.9
|
30.1
|
1.0
|
CB
|
C:THR509
|
5.0
|
34.7
|
1.0
|
|
Fluorine binding site 7 out
of 12 in 8uv2
Go back to
Fluorine Binding Sites List in 8uv2
Fluorine binding site 7 out
of 12 in the Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 7 of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F903
b:60.7
occ:1.00
|
F17
|
D:XKM903
|
0.0
|
60.7
|
1.0
|
C16
|
D:XKM903
|
1.3
|
64.4
|
1.0
|
C18
|
D:XKM903
|
2.2
|
62.7
|
1.0
|
C15
|
D:XKM903
|
2.3
|
64.8
|
1.0
|
C14
|
D:XKM903
|
2.9
|
60.5
|
1.0
|
CD1
|
D:LEU504
|
3.0
|
26.3
|
1.0
|
O
|
D:PRO500
|
3.1
|
21.5
|
1.0
|
CB
|
D:PRO500
|
3.3
|
21.2
|
1.0
|
CB
|
D:PHE503
|
3.3
|
19.0
|
1.0
|
CA
|
D:PRO500
|
3.4
|
17.9
|
1.0
|
C19
|
D:XKM903
|
3.4
|
64.7
|
1.0
|
C41
|
D:XKM903
|
3.5
|
64.4
|
1.0
|
C
|
D:PRO500
|
3.7
|
20.3
|
1.0
|
C13
|
D:XKM903
|
3.7
|
59.2
|
1.0
|
C40
|
D:XKM903
|
4.0
|
64.4
|
1.0
|
N
|
D:LEU504
|
4.1
|
26.2
|
1.0
|
C
|
D:PHE503
|
4.2
|
24.2
|
1.0
|
CA
|
D:PHE503
|
4.2
|
20.1
|
1.0
|
CG
|
D:PHE503
|
4.3
|
19.0
|
1.0
|
O20
|
D:XKM903
|
4.4
|
65.5
|
1.0
|
CG
|
D:LEU504
|
4.5
|
27.8
|
1.0
|
O
|
D:PRO496
|
4.6
|
24.8
|
1.0
|
F42
|
D:XKM903
|
4.7
|
62.0
|
1.0
|
N
|
D:PHE503
|
4.7
|
19.4
|
1.0
|
CG
|
D:PRO500
|
4.7
|
24.3
|
1.0
|
O
|
D:PHE503
|
4.7
|
26.8
|
1.0
|
N
|
D:PRO500
|
4.8
|
16.0
|
1.0
|
CB
|
D:LEU504
|
4.8
|
26.3
|
1.0
|
CA
|
D:LEU504
|
4.9
|
26.4
|
1.0
|
CD1
|
D:PHE503
|
4.9
|
22.4
|
1.0
|
C12
|
D:XKM903
|
5.0
|
60.4
|
1.0
|
N
|
D:ASP501
|
5.0
|
22.2
|
1.0
|
|
Fluorine binding site 8 out
of 12 in 8uv2
Go back to
Fluorine Binding Sites List in 8uv2
Fluorine binding site 8 out
of 12 in the Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 8 of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F903
b:62.0
occ:1.00
|
F42
|
D:XKM903
|
0.0
|
62.0
|
1.0
|
C41
|
D:XKM903
|
1.3
|
64.4
|
1.0
|
C40
|
D:XKM903
|
2.3
|
64.4
|
1.0
|
C15
|
D:XKM903
|
2.4
|
64.8
|
1.0
|
C14
|
D:XKM903
|
2.9
|
60.5
|
1.0
|
CD
|
D:PRO510
|
3.4
|
19.9
|
1.0
|
C16
|
D:XKM903
|
3.5
|
64.4
|
1.0
|
C19
|
D:XKM903
|
3.5
|
64.7
|
1.0
|
C13
|
D:XKM903
|
3.7
|
59.2
|
1.0
|
NZ
|
D:LYS615
|
3.8
|
19.3
|
1.0
|
CG
|
D:PRO510
|
3.9
|
12.2
|
1.0
|
C18
|
D:XKM903
|
4.0
|
62.7
|
1.0
|
CE
|
D:LYS615
|
4.0
|
18.2
|
1.0
|
CD
|
D:LYS615
|
4.1
|
23.2
|
1.0
|
CA
|
D:THR509
|
4.1
|
23.9
|
1.0
|
N
|
D:PRO510
|
4.2
|
16.2
|
1.0
|
C
|
D:THR509
|
4.5
|
20.5
|
1.0
|
N36
|
D:XKM903
|
4.5
|
62.0
|
1.0
|
F17
|
D:XKM903
|
4.7
|
60.7
|
1.0
|
O20
|
D:XKM903
|
4.7
|
65.5
|
1.0
|
C35
|
D:XKM903
|
4.8
|
61.5
|
1.0
|
N
|
D:THR509
|
4.9
|
23.6
|
1.0
|
CB
|
D:THR509
|
5.0
|
27.1
|
1.0
|
|
Fluorine binding site 9 out
of 12 in 8uv2
Go back to
Fluorine Binding Sites List in 8uv2
Fluorine binding site 9 out
of 12 in the Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 9 of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:F903
b:57.9
occ:1.00
|
F17
|
E:XKM903
|
0.0
|
57.9
|
1.0
|
C16
|
E:XKM903
|
1.3
|
61.0
|
1.0
|
C18
|
E:XKM903
|
2.2
|
58.7
|
1.0
|
C15
|
E:XKM903
|
2.3
|
63.0
|
1.0
|
C14
|
E:XKM903
|
2.9
|
59.5
|
1.0
|
CD1
|
E:LEU504
|
3.0
|
32.8
|
1.0
|
O
|
E:PRO500
|
3.1
|
30.2
|
1.0
|
CB
|
E:PRO500
|
3.2
|
30.7
|
1.0
|
CB
|
E:PHE503
|
3.3
|
22.4
|
1.0
|
CA
|
E:PRO500
|
3.3
|
24.8
|
1.0
|
C19
|
E:XKM903
|
3.4
|
60.6
|
1.0
|
C41
|
E:XKM903
|
3.5
|
62.9
|
1.0
|
C
|
E:PRO500
|
3.6
|
28.5
|
1.0
|
C13
|
E:XKM903
|
3.7
|
57.6
|
1.0
|
N
|
E:LEU504
|
4.0
|
36.2
|
1.0
|
C40
|
E:XKM903
|
4.0
|
62.3
|
1.0
|
C
|
E:PHE503
|
4.2
|
35.1
|
1.0
|
CA
|
E:PHE503
|
4.3
|
26.6
|
1.0
|
CG
|
E:PHE503
|
4.3
|
25.8
|
1.0
|
O20
|
E:XKM903
|
4.4
|
61.1
|
1.0
|
CG
|
E:LEU504
|
4.5
|
40.4
|
1.0
|
O
|
E:PRO496
|
4.6
|
41.1
|
1.0
|
F42
|
E:XKM903
|
4.7
|
59.5
|
1.0
|
N
|
E:PHE503
|
4.7
|
27.9
|
1.0
|
CG
|
E:PRO500
|
4.7
|
34.0
|
1.0
|
N
|
E:PRO500
|
4.7
|
20.9
|
1.0
|
CB
|
E:LEU504
|
4.8
|
37.6
|
1.0
|
CA
|
E:LEU504
|
4.8
|
36.0
|
1.0
|
CD1
|
E:PHE503
|
4.8
|
33.5
|
1.0
|
O
|
E:PHE503
|
4.9
|
37.7
|
1.0
|
N
|
E:ASP501
|
4.9
|
31.5
|
1.0
|
C12
|
E:XKM903
|
5.0
|
57.8
|
1.0
|
|
Fluorine binding site 10 out
of 12 in 8uv2
Go back to
Fluorine Binding Sites List in 8uv2
Fluorine binding site 10 out
of 12 in the Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 10 of Human P97/Vcp Structure with A Triazole Inhibitor (NSC799462/Hexamer) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:F903
b:59.5
occ:1.00
|
F42
|
E:XKM903
|
0.0
|
59.5
|
1.0
|
C41
|
E:XKM903
|
1.3
|
62.9
|
1.0
|
C40
|
E:XKM903
|
2.3
|
62.3
|
1.0
|
C15
|
E:XKM903
|
2.4
|
63.0
|
1.0
|
C14
|
E:XKM903
|
2.9
|
59.5
|
1.0
|
CD
|
E:PRO510
|
3.4
|
33.6
|
1.0
|
C16
|
E:XKM903
|
3.5
|
61.0
|
1.0
|
C19
|
E:XKM903
|
3.5
|
60.6
|
1.0
|
C13
|
E:XKM903
|
3.7
|
57.6
|
1.0
|
NZ
|
E:LYS615
|
3.9
|
29.6
|
1.0
|
CG
|
E:PRO510
|
3.9
|
22.7
|
1.0
|
C18
|
E:XKM903
|
4.0
|
58.7
|
1.0
|
CE
|
E:LYS615
|
4.0
|
29.8
|
1.0
|
CD
|
E:LYS615
|
4.1
|
32.8
|
1.0
|
CA
|
E:THR509
|
4.1
|
37.3
|
1.0
|
N
|
E:PRO510
|
4.2
|
27.2
|
1.0
|
N36
|
E:XKM903
|
4.5
|
59.5
|
1.0
|
C
|
E:THR509
|
4.5
|
31.8
|
1.0
|
F17
|
E:XKM903
|
4.7
|
57.9
|
1.0
|
C35
|
E:XKM903
|
4.7
|
59.2
|
1.0
|
O20
|
E:XKM903
|
4.7
|
61.1
|
1.0
|
N
|
E:THR509
|
4.9
|
37.7
|
1.0
|
|
Reference:
P.Nandi,
K.Devore,
F.Wang,
S.Li,
J.D.Walker,
T.T.Truong,
M.G.Laporte,
P.Wipf,
H.Schlager,
J.Mccleerey,
W.Paquette,
R.C.A.Columbres,
T.Gan,
Y.P.Poh,
P.Fromme,
A.J.Flint,
M.Wolf,
D.M.Huryn,
T.F.Chou,
P.L.Chiu.
Mechanism of Allosteric Inhibition of Human P97/Vcp Atpase and Its Disease Mutant By Triazole Inhibitors. Commun Chem V. 7 177 2024.
ISSN: ESSN 2399-3669
PubMed: 39122922
DOI: 10.1038/S42004-024-01267-3
Page generated: Sat Sep 28 20:34:16 2024
|